Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Ticker SymbolARAY
Company nameAccuray Inc
IPO dateFeb 08, 2007
CEOMs. Suzanne C. Winter
Number of employees987
Security typeOrdinary Share
Fiscal year-endFeb 08
Address1240 Deming Way
CityMADISON
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code53717
Phone16088242800
Websitehttps://www.accuray.com/
Ticker SymbolARAY
IPO dateFeb 08, 2007
CEOMs. Suzanne C. Winter
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data